Saphris – Think Schizophrenia or Bipolar

I suppose Saphris sounds better than asenapine.

Medical News: FDA Okays New Antipsychotic for Schizophrenia, Bipolar Disorder – in Product Alert, Prescriptions from MedPage Today

FDA approval was based on data from more than 3,000 patients showing statistically significant efficacy versus placebo in acute schizophrenia trials and statistically significant reduction of bipolar mania symptoms versus placebo.

Question of the Day – August 7, 2009 – Can Businesses Really Do More With Less?

At the end of 2007 a large Midwestern US insurance company instituted mandatory 55 hour workweeks for their underwriters.

A year later, that same company a laid off a bunch of  people.  Some of these employees were the same people from whom management mandated OT from just one year prior.

The hamsters are dying.  I don’t think they can do more with less.  Time for a new business model.

My answer to the question is NO.

Businesses Learn To Make Do With Fewer Workers : NPR

Since December 2007, the labor market has seen a net decline of 6.5 million jobs.